FUNDING OPPORTUNITIES - BackAwards in Gene Therapy for Lymphoma
and Leukemia
Alliance for Cancer Gene Therapy, Inc.
(ACGT) funds research aimed at furthering the development of gene
therapy approaches to the treatment of cancer. To this end, ACGT
announces its Gene Therapy For Lymphoma And Leukemia Award to qualified
scientists at the assistant professor level and above who are working
in the field of gene therapy for lymphoma and leukemia. The overall
objectives of this grant are to advance gene therapy into the causes,
treatment and prevention of lymphoma and leukemia by promoting basic
and pre-clinical research approaches utilizing cells and genes as
medicine, as well as clinical translational studies.
Each grant will be awarded up to $1,000,000
over a period of three to five years (inclusive of 10% indirect
cost). The deadline is February 16, 2004. All applications
are accepted through proposalCENTRAL, http://pc.ecgrant.com/.
Please visit www.acgtfoundation.org
to view details including eligibility requirements and application
forms.
Return to top of Funding Opportunities
|
